METHODS, REGIMENS, COMBINATIONS & ANTAGONISTS

The invention relates to treating or preventing anemia in a subject, such as a mammal or human. In particular, the invention addresses moderate to severe anemia. Additionally, the invention provides means for sparing administration of erythropoiesis stimulating agents (ESAs) to subjects. 本发明涉及治疗或预防如...

Full description

Saved in:
Bibliographic Details
Main Authors GERMASCHEWSKI VOLKER, ARKINSTALL STEVE, THEURL IGOR, YATEMAN MARTIN, CLUBE JASPER
Format Patent
LanguageChinese
English
Published 04.01.2019
Subjects
Online AccessGet full text

Cover

More Information
Summary:The invention relates to treating or preventing anemia in a subject, such as a mammal or human. In particular, the invention addresses moderate to severe anemia. Additionally, the invention provides means for sparing administration of erythropoiesis stimulating agents (ESAs) to subjects. 本发明涉及治疗或预防如哺乳动物或人等受试者的贫血。具体地,本发明解决了中度到重度贫血。另外,本发明提供了用于免除对受试者施用红细胞生成刺激剂(ESA)的手段。
Bibliography:Application Number: CN201780027052